CU NR 546
Active symptoms - ANS-Depression
Anxiety
Suicidality
Adherence - ANS-can be defined as persistence or compliance.
Persistence is taking the medication over the intended time period.
Compliance is taking the medication as prescribed. According to Dell'Osso et al. (2020), client,
clinician, and structural factors all contribute to non-adherence.
Amygdala - ANS-Involved in emotional regulation and perception of odors
antagonist effect - ANS-antagonist effect - drug binds to receptor, but does not activate a
response
Antipsychotic medications - ANS-can be effective in reducing the symptoms of psychosis.
Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side effects
to the drugs used for chemical restraint? - ANS-No. The client has been court-ordered to take
the prescribed medications and the standing order for chemical restraints is approved. The
PMHNP and other staff are not liable if the patient has an allergic reaction or adverse side
effects.
Basal ganglia - ANS-A group of structures involved in voluntary motor movements
Basal ganglia - ANS-are a group of structures involved in voluntary motor movements. Basal
ganglia are also involved in cognition and emotion.
Brain tissue - ANS-is composed of gray and white matter.
Brain tissue - ANS-Made up of grey matter and white matter
Broca's area - ANS-Speech
Cerebellum - ANS-coordination and balance
Client factors that contribute to nonadherence include - ANS-concern about
side effects,
, fear of addiction to medications,
misunderstanding of expected outcomes.
Clinician factors that contribute to nonadherence include - ANS-lack of shared-decision making
with the client, providing inadequate education about medications, and lack of follow up.
Cognition - ANS-Attention
Working memory
Verbal memory
Visual memory
Executive functioning
Processing speed
Social conditioning
Compliance - ANS-A court order may be issued for a client to receive treatment against their
wishes if they are considered a danger to themselves or others.
Examples include clients with schizophrenia or sex offenders. Guardians can also provide
consent for clients who have limited cognitive capabilities or are incompetent to make decisions.
Ultimately, PMHNPs are responsible for being knowledgeable about their state laws and abiding
by them.
Corpus callosum - ANS-Controls the communication between the two brain hemispheres
Diagnoses Requiring the Presence of Psychosis - ANS-schizophrenia
substance-induced psychotic disorders
schizophreniform disorder
schizoaffecive disorder
delusional disorder
brief psychotic disorder
psychotic disorder due to a medical condition
Diagnoses with Psychosis as a Feature - ANS-mania
depression
cognitive disorders
dementia
Dopamine Role in Psychosis - ANS-Many theories exist regarding the causes of psychosis and
schizophrenia. A leading hypothesis is that psychosis and schizophrenia are associated with a
dysfunction of the neurotransmitter dopamine (DA) (Stahl, 2021).
Active symptoms - ANS-Depression
Anxiety
Suicidality
Adherence - ANS-can be defined as persistence or compliance.
Persistence is taking the medication over the intended time period.
Compliance is taking the medication as prescribed. According to Dell'Osso et al. (2020), client,
clinician, and structural factors all contribute to non-adherence.
Amygdala - ANS-Involved in emotional regulation and perception of odors
antagonist effect - ANS-antagonist effect - drug binds to receptor, but does not activate a
response
Antipsychotic medications - ANS-can be effective in reducing the symptoms of psychosis.
Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side effects
to the drugs used for chemical restraint? - ANS-No. The client has been court-ordered to take
the prescribed medications and the standing order for chemical restraints is approved. The
PMHNP and other staff are not liable if the patient has an allergic reaction or adverse side
effects.
Basal ganglia - ANS-A group of structures involved in voluntary motor movements
Basal ganglia - ANS-are a group of structures involved in voluntary motor movements. Basal
ganglia are also involved in cognition and emotion.
Brain tissue - ANS-is composed of gray and white matter.
Brain tissue - ANS-Made up of grey matter and white matter
Broca's area - ANS-Speech
Cerebellum - ANS-coordination and balance
Client factors that contribute to nonadherence include - ANS-concern about
side effects,
, fear of addiction to medications,
misunderstanding of expected outcomes.
Clinician factors that contribute to nonadherence include - ANS-lack of shared-decision making
with the client, providing inadequate education about medications, and lack of follow up.
Cognition - ANS-Attention
Working memory
Verbal memory
Visual memory
Executive functioning
Processing speed
Social conditioning
Compliance - ANS-A court order may be issued for a client to receive treatment against their
wishes if they are considered a danger to themselves or others.
Examples include clients with schizophrenia or sex offenders. Guardians can also provide
consent for clients who have limited cognitive capabilities or are incompetent to make decisions.
Ultimately, PMHNPs are responsible for being knowledgeable about their state laws and abiding
by them.
Corpus callosum - ANS-Controls the communication between the two brain hemispheres
Diagnoses Requiring the Presence of Psychosis - ANS-schizophrenia
substance-induced psychotic disorders
schizophreniform disorder
schizoaffecive disorder
delusional disorder
brief psychotic disorder
psychotic disorder due to a medical condition
Diagnoses with Psychosis as a Feature - ANS-mania
depression
cognitive disorders
dementia
Dopamine Role in Psychosis - ANS-Many theories exist regarding the causes of psychosis and
schizophrenia. A leading hypothesis is that psychosis and schizophrenia are associated with a
dysfunction of the neurotransmitter dopamine (DA) (Stahl, 2021).